Literature DB >> 30535924

Providing Evidence: Step by Step-a Letter from Associate Editor, Tobias Else, MD.

Tobias Else1.   

Abstract

Year:  2019        PMID: 30535924     DOI: 10.1007/s12672-018-0355-4

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


× No keyword cloud information.
  4 in total

1.  Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.

Authors:  Shiko Asai; Takuyuki Katabami; Mika Tsuiki; Yasushi Tanaka; Mitsuhide Naruse
Journal:  Horm Cancer       Date:  2017-01-20       Impact factor: 3.869

2.  Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients.

Authors:  Julien Hadoux; Marie Terroir; Sophie Leboulleux; Frederic Deschamps; Abir Al Ghuzlan; Ségolène Hescot; Lambros Tselikas; Isabelle Borget; Caroline Caramella; Desirée Déandréis; Diane Goere; Thierry De Baere; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2017-07-26       Impact factor: 3.869

3.  Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.

Authors:  Delphine Vezzosi; Christine Do Cao; Ségolène Hescot; Jérôme Bertherat; Magali Haissaguerre; Vanina Bongard; Delphine Drui; Christelle De La Fouchardière; Frédéric Illouz; Françoise Borson-Chazot; Bodale Djobo; Amandine Berdelou; Antoine Tabarin; Martin Schlumberger; Claire Briet; Philippe Caron; Sophie Leboulleux; Rossella Libe; Eric Baudin
Journal:  Horm Cancer       Date:  2017-10-25       Impact factor: 3.869

4.  Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.

Authors:  Mauricio P Pinto; Matías Muñoz Medel; Diego Carrillo; Ignacio N Retamal; M Loreto Bravo; Yasna Valenzuela; Bruno Nervi; César Sánchez; Héctor Galindo; Carolina Ibañez; José Peña; Carlos Balmaceda; Jorge Madrid; Juan Briones; Javiera Torres; Flavia Nilo; Francisco J Guarda; Juan Carlos Quintana; Pilar Orellana; Sebastián Mondaca; Francisco Acevedo; Daniel Vicentini; Miguel Cordova-Delgado; Gareth I Owen; Marcelo Garrido
Journal:  Horm Cancer       Date:  2018-11-22       Impact factor: 3.869

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.